@BenDelecto @angie_rasmussen The problem is, they're not especially good at preventing symptomatic disease from Omicron. You're using a vaccine for a virus that no longer circulates. It fortunately retains some efficacy, but it's not great, and certainly not up to the original non-goalpost-moved standards.
@BenDelecto@angie_rasmussen问题是，他们在预防Omicron的症状性疾病方面并不特别擅长。你使用的是一种不再传播的病毒疫苗。幸运的是，它保留了一些效力，但不是很好，当然也没有达到最初的非进球标准。